N95 Face Masks Get Pathogen Killing Technology with Addition of New UVC Medical Device

By HospiMedica International staff writers
Posted on 24 Jun 2020

A new low-cost UVC medical device adds pathogen killing technology for N95 face masks that is effective on COVID-19.

N95 masks act as a barrier to help prevent the spread of pathogens in droplets from being exhaled and inhaled, but do not provide the capability to kill pathogens. The technology developed by Brite-Strike Technologies Inc. (Duxbury, MA, USA) adds this critical component to N95 masks. The micro device can be installed in any N95 in seconds and can also be used in conjunction with hydrogen peroxide and a heat source to decontaminate a single user N95 mask in the field.

Illustration

The company, which holds numerous patents related to LED light in visible, IR (infrared) and UV (ultraviolet) light as well as UV light for sterilization of air and water, has received FDA Pre-EAU approval to begin testing the device.

Related Links:
Brite-Strike Technologies Inc.